Compositions comprising sclareol or derivatives thereof and uses thereof
AssigneeAvoca, Inc.
InventorsDavid Peele, Dilip Chokshi
Life of this patent
Estimating the term…
Abstract
The present invention provides a composition which includes a sclareol or a derivative thereof, wherein the sclareol or a derivative thereof is bound by a glycoprotein matrix. The composition of the invention provides improved potency, stability and bioactivity characteristics of sclareol, or its derivatives.
Claims26
A composition comprising sclareol or a derivative thereof, wherein the sclareol or derivative thereof is bound by a glycoprotein matrix.
A method for increasing cyclic adenosine monophosphate (cAMP) activity in a host in need thereof, the method comprises administering to said host, an effective amount of a composition comprising sclareol or a derivative thereof, wherein the sclareol or derivative thereof is bound by a glycoprotein matrix.
A method according to claim 13, wherein the derivative is sclareolide.
A method according to claim 13 further comprising microorganisms.
A method according to claim 13, wherein said glycoprotein matrix is obtained by fermenting microorganisms together with the sclareol or derivative thereof.
A method for inducing weight loss in a host in need thereof, the method comprises administering to said host, an effective amount of a composition comprising sclareol or a derivative thereof, wherein the sclareol or derivative thereof is bound by a glycoprotein matrix.
A method for increasing libido in a host, the method comprises administering to said host, an effective amount of a composition comprising sclareol or a derivative thereof, wherein the sclareol or derivative thereof is bound by a glycoprotein matrix.
A method for increasing lipolysis in a host, the method comprises administering to said host, an effective amount of a composition comprising sclareol or a derivative thereof, wherein the sclareol or derivative thereof is bound by a glycoprotein matrix.
A method for inhibiting adipogenesis in a host, the method comprises administering to said host, an effective amount of a composition comprising sclareol or a derivative thereof, wherein the sclareol or derivative thereof is bound by a glycoprotein matrix.
Dependencies are inferred from the claim text.